SPHY vs. CVS
SPHY (SPDR Portfolio High Yield Bond ETF) is High Yield Bonds fund tracking the ICE BofA US High Yield Index, while CVS (CVS Health Corporation) is a stock. Over the past 10 years, SPHY returned 5.21%/yr vs 3.70%/yr for CVS. At a 0.16 correlation, their price movements are largely independent.
Performance
SPHY vs. CVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPHY achieves a 1.85% return, which is significantly lower than CVS's 30.67% return. Over the past 10 years, SPHY has outperformed CVS with an annualized return of 5.21%, while CVS has yielded a comparatively lower 3.70% annualized return.
SPHY
- 1D
- 0.04%
- 1M
- 0.63%
- YTD
- 1.85%
- 6M
- 2.41%
- 1Y
- 7.07%
- 3Y*
- 8.90%
- 5Y*
- 4.36%
- 10Y*
- 5.21%
CVS
- 1D
- 1.47%
- 1M
- 3.92%
- YTD
- 30.67%
- 6M
- 30.57%
- 1Y
- 59.29%
- 3Y*
- 16.60%
- 5Y*
- 7.08%
- 10Y*
- 3.70%
SPHY vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPHY SPDR Portfolio High Yield Bond ETF | 1.85% | 8.59% | 8.54% | 12.81% | -10.57% | 5.61% | 6.65% | 13.16% | -3.35% | 7.35% |
CVS CVS Health Corporation | 30.67% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -7.04% | -5.75% |
Correlation
The correlation between SPHY and CVS is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jun 19, 2012 | 0.16 |
The correlation between SPHY and CVS shifts across timeframes, from 0.03 (1 year) to 0.20 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPHY vs. CVS — Risk / Return Rank
SPHY
CVS
SPHY vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR Portfolio High Yield Bond ETF (SPHY) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPHY | CVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.01 | ||
| Sortino ratioReturn per unit of downside risk | +0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.35 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.94 | 3.62 | -0.68 |
| Martin ratioReturn relative to average drawdown | 13.29 | 9.33 | +3.96 |
Loading charts...
Drawdowns
SPHY vs. CVS - Drawdown Comparison
The maximum SPHY drawdown since its inception was -21.97%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for SPHY and CVS.
Loading charts...
Drawdown Indicators
| SPHY | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.97% | -64.07% | +42.10% |
Max Drawdown (1Y)Largest decline over 1 year | -2.41% | -16.44% | +14.03% |
Max Drawdown (3Y)Largest decline over 3 years | -4.85% | -43.98% | +39.13% |
Max Drawdown (5Y)Largest decline over 5 years | -15.29% | -56.79% | +41.50% |
Max Drawdown (10Y)Largest decline over 10 years | -21.97% | -56.79% | +34.82% |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -2.29% | -19.54% | +17.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.53% | 6.38% | -5.85% |
Volatility
SPHY vs. CVS - Volatility Comparison
The current volatility for SPDR Portfolio High Yield Bond ETF (SPHY) is 1.16%, while CVS Health Corporation (CVS) has a volatility of 7.50%. This indicates that SPHY experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPHY | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.16% | 7.50% | -6.34% |
Volatility (6M)Calculated over the trailing 6-month period | 2.95% | 25.88% | -22.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 3.72% | 31.05% | -27.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 7.18% | 29.98% | -22.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 7.87% | 29.30% | -21.43% |
Dividends
SPHY vs. CVS - Dividend Comparison
SPHY's dividend yield for the trailing twelve months is around 7.24%, more than CVS's 2.61% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVS CVS Health Corporation | 2.61% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
SPHY SPDR Portfolio High Yield Bond ETF | 7.24% | 7.38% | 7.80% | 7.30% | 6.47% | 5.13% | 5.63% | 5.73% | 4.09% | 4.41% | 4.27% | 4.29% |
Frequently Asked Questions
SPHY and CVS have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVS has higher volatility (7.50%) compared to SPHY (1.16%). In terms of maximum drawdown, SPHY dropped -21.97% vs CVS's -64.07%.
CVS currently has the higher Sharpe Ratio (1.92 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPHY and CVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer